{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:46:53Z","timestamp":1790750813520,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009512","name":"Ritsumeikan Global Innovation Research Organization, Ritsumeikan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009512","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005405","name":"Ritsumeikan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005405","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.bbrc.2015.01.022","type":"journal-article","created":{"date-parts":[[2015,1,16]],"date-time":"2015-01-16T11:48:53Z","timestamp":1421408933000},"page":"547-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor"],"prefix":"10.1016","volume":"457","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0861-6697","authenticated-orcid":false,"given":"Naoki","family":"Yamamoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Hirate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyoshi","family":"Kusama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2015.01.022_bib1","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1582-4934.2008.00225.x","article-title":"Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention","volume":"12","author":"Iqbal","year":"2008","journal-title":"J.\u00a0Cell. Mol. Med."},{"key":"10.1016\/j.bbrc.2015.01.022_bib2","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fnins.2010.00272","article-title":"Alzheimer's disease and anesthesia","volume":"4","author":"Papon","year":"2011","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.bbrc.2015.01.022_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00000542-200409000-00019","article-title":"Inhaled anesthetic enhancement of amyloid-beta oligomerization and cytotoxicity","volume":"101","author":"Eckenhoff","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2015.01.022_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/ALN.0b013e31824be8c7","article-title":"Tau phosphorylation and sevoflurane anesthesia: an association to postoperative cognitive impairment","volume":"116","author":"Le Freche","year":"2012","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2015.01.022_bib5","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1096\/fj.08-122424","article-title":"Acceleration and persistence of neurofibrillary pathology in a mouse model of tauopathy following anesthesia","volume":"23","author":"Planel","year":"2009","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2015.01.022_bib6","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3233\/JAD-2009-1003","article-title":"Anesthesia induces phosphorylation of tau","volume":"16","author":"Run","year":"2009","journal-title":"J.\u00a0Alzheimers. Dis."},{"key":"10.1016\/j.bbrc.2015.01.022_bib7","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/EJA.0b013e32833a6561","article-title":"Tau hyperphosphorylation is associated with memory impairment after exposure to 1.5% isoflurane without temperature maintenance in rats","volume":"27","author":"Tan","year":"2010","journal-title":"Eur. J. Anaesthesiol."},{"key":"10.1016\/j.bbrc.2015.01.022_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/ALN.0b013e31822e9306","article-title":"Human Alzheimer and inflammation biomarkers after anesthesia and surgery","volume":"115","author":"Tang","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2015.01.022_bib9","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.exger.2006.01.014","article-title":"Alzheimer's disease and post-operative cognitive dysfunction","volume":"41","author":"Xie","year":"2006","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.bbrc.2015.01.022_bib10","doi-asserted-by":"crossref","first-page":"6084","DOI":"10.1016\/S0021-9258(17)38495-8","article-title":"Microtubule-associated protein tau. A component of Alzheimer paired helical filaments","volume":"261","author":"Grundke-Iqbal","year":"1986","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.01.022_bib11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2015.01.022_bib12","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1152\/physrev.2001.81.2.741","article-title":"Alzheimer's disease: genes, protein, and therapy","volume":"81","author":"Selkoe","year":"2001","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbrc.2015.01.022_bib13","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1038\/nm1095-1062","article-title":"GM1 ganglioside-bound amyloid \u03b2-protein (\u0391\u03b2): a possible form of preamyloid in Alzheimer's disease","volume":"1","author":"Yanagisawa","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2015.01.022_bib14","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/j.1471-4159.2010.07006.x","article-title":"Pathological significance of ganglioside clusters in Alzheimer's disease","volume":"116","author":"Yanagisawa","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2015.01.022_bib15","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1523\/JNEUROSCI.0861-04.2004","article-title":"A\u00a0seed for Alzheimer amyloid in the brain","volume":"24","author":"Hayashi","year":"2004","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2015.01.022_bib16","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.bbamem.2007.01.009","article-title":"GM1-ganglioside-induced \u0391\u03b2 assembly on synaptic membranes of cultured neurons","volume":"1768","author":"Yamamoto","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2015.01.022_bib17","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1016\/j.bbamem.2008.07.028","article-title":"Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid \u03b2-protein fibrillogenesis","volume":"1778","author":"Yamamoto","year":"2008","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbrc.2015.01.022_bib18","doi-asserted-by":"crossref","first-page":"7226","DOI":"10.1523\/JNEUROSCI.21-18-07226.2001","article-title":"A\u00a0novel action of Alzheimer's amyloid \u03b2-protein (\u0391\u03b2): oligomeric \u0391\u03b2 promotes lipid release","volume":"21","author":"Michikawa","year":"2001","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.bbrc.2015.01.022_bib19","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.febslet.2004.05.037","article-title":"Accelerated \u0391\u03b2 aggregation in the presence of GM1-ganglioside-accumulated synaptosomes of aged apoE4-knock-in mouse brain","volume":"569","author":"Yamamoto","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbrc.2015.01.022_bib20","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0076-6879(99)09022-9","article-title":"Kinetic analysis of amyloid fibril formation","volume":"309","author":"Naiki","year":"1999","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.bbrc.2015.01.022_bib21","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1471-4159.2004.02459.x","article-title":"Environment- and mutation-dependent aggregation behavior of Alzheimer amyloid \u03b2-protein","volume":"90","author":"Yamamoto","year":"2004","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2015.01.022_bib22","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1097\/ALN.0b013e31828afc16","article-title":"Propofol and thiopental suppress amyloid fibril formation and GM1 ganglioside expression through the \u03b3-aminobutyric acid a receptor","volume":"118","author":"Yamamoto","year":"2013","journal-title":"Anesthesiology"},{"key":"10.1016\/j.bbrc.2015.01.022_bib23","doi-asserted-by":"crossref","first-page":"22364","DOI":"10.1074\/jbc.272.35.22364","article-title":"Amyloid beta-protein fibrillogenesis. detection of a protofibrillar intermediate","volume":"272","author":"Walsh","year":"1997","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.bbrc.2015.01.022_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1471-4159.2004.02849.x","article-title":"Structural membrane alterations in Alzheimer brains found to be associated with regional disease development; increased density of gangliosides GM1 and GM2 and loss of cholesterol in detergent-resistant membrane domains","volume":"92","author":"Molander-Melin","year":"2005","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2015.01.022_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.neurobiolaging.2005.10.018","article-title":"Increase cholesterol in \u0391\u03b2-positive nerve terminals from Alzheimer's disease cortex","volume":"28","author":"Gylys","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.bbrc.2015.01.022_bib26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0304-3940(90)90754-W","article-title":"Alzheimer patients and down patients: abnormal presynaptic terminals are related to cerebral preamyloid deposits","volume":"119","author":"Bugiani","year":"1990","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bbrc.2015.01.022_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00294426","article-title":"Deposition of \u03b2\/A4 protein along neuronal plasma membranes in diffuse senile plaques","volume":"83","author":"Probst","year":"1991","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbrc.2015.01.022_bib28","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1471-4159.2012.07668.x","article-title":"Brain insulin resistance accelerates \u0391\u03b2 fibrillogenesis by inducing GM1 ganglioside clustering in the presynaptic membranes","volume":"121","author":"Yamamoto","year":"2012","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2015.01.022_bib29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/978-3-540-74806-9_16","article-title":"Midazolam and other benzodiazepines","volume":"182","author":"Olkkola","year":"2008","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bbrc.2015.01.022_bib30","first-page":"292","article-title":"Effects of propofol, midazolam and thiopental sodium on outcome and amino acids accumulation in focal cerebral ischemia-reperfusion in rats","volume":"116","author":"Chen","year":"2003","journal-title":"Chin. Med. J. Engl."},{"key":"10.1016\/j.bbrc.2015.01.022_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/ANA.0b013e318191697a","article-title":"Effects of midazolam on brain injury after transient focal cerebral ischemia in rats","volume":"21","author":"Lei","year":"2009","journal-title":"J.\u00a0Neurosurg. Anesthesiol."},{"key":"10.1016\/j.bbrc.2015.01.022_bib32","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00381-012-1782-0","article-title":"Neuroprotective effects of propofol, thiopental, etomidate, and midazolam in fetal rat brain in ischemia-reperfusion model","volume":"28","author":"Harman","year":"2012","journal-title":"Childs Nerv. Syst."},{"key":"10.1016\/j.bbrc.2015.01.022_bib33","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1177\/070674370404900705","article-title":"GABAergic function in Alzheimer's disease: evidence for dysfunction and potential as a therapeutic target for the treatment of behavioural and psychological symptoms of dementia","volume":"49","author":"Lanct\u00f4t","year":"2004","journal-title":"Can. J. Psychiatry"},{"key":"10.1016\/j.bbrc.2015.01.022_bib34","first-page":"613","article-title":"Implications for treatment: GABAA receptors in aging, down syndrome and Alzheimer's disease","volume":"117","author":"Rissman","year":"2011","journal-title":"J.\u00a0Neurochem."},{"key":"10.1016\/j.bbrc.2015.01.022_bib35","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1096\/fj.03-0739com","article-title":"Taurine prevents the neurotoxicity of \u03b2-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders","volume":"18","author":"Louzada","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.bbrc.2015.01.022_bib36","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1016\/j.neurobiolaging.2005.09.034","article-title":"The amyloid pathology progresses in a neurotransmitter-specific manner","volume":"27","author":"Bell","year":"2006","journal-title":"Neurobiol. Aging"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X15000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:29:51Z","timestamp":1762093791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X15000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S0006291X15000443"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.01.022","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Midazolam inhibits the formation of amyloid fibrils and GM1 ganglioside-rich microdomains in presynaptic membranes through the gamma-aminobutyric acid A receptor","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2015.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}